Author Verified
Published: Aug 2009
ACE Report #444
Ace Report Cover General Orthopaedics

TNF antagonist better in treatment of early rheumatoid arthritis

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Lancet. 2009 Aug 8;374(9688):459-66.

Contributing Authors: RF van Vollenhoven S Ernestam P Geborek IF Petersson L Cöster E Waltbrand A Zickert J Theander A Thörner H Hellström A Teleman C Dackhammar F Akre K Forslind L Ljung R Oding A Chatzidionysiou M Wörnert J Bratt

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.